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ABSTRACT 
 
The Heparin-Binding EGF-like Growth Factor (HB-EGF) is an autocrine/paracrine 
keratinocyte growth factor which binds to the EGF (Epidermal Growth Factor) receptor 
family and plays a critical role during the re-epithelialization of cutaneous wound by 
stimulating the keratinocytes proliferation and migration. In this study, cellular stressing 
condition in autocrine cultures of human keratinocytes was induced by cholesterol depletion 
methyl-beta-cyclodextrin (MCD). MCD treatment induces the expression and the release of 
HB-EGF. By analysis of the culture media, large amounts of cellular ATP were measured 
particularly after 1h of MCD treatment. To investigate whether ATP contributes to the 
expression of HB-EGF, the nonhydrolyzable ATP analogue, ATP-S, was used to mimic the 
extracellular ATP released. We report that keratinocytes stimulated with ATP--S induce HB-
EGF expression and activate EGFR and ERK1/2. Using an antagonist of P2 purinergic 
receptors, we demonstrate that HB-EGF synthesis induced by lipid rafts disruption is 
dependent on ATP interaction with P2 purinergic receptors. Moreover, our data suggest that 
both MAPKs p38 and ERK1/2 are involved together or independently in the regulation of 
HB-EGF gene expression. These findings provide new insight into the signalling pathway by 
which HB-EGF is expressed after lipid rafts disruption. In summary, after lipid raft 
disruption, keratinocytes release large amount of extracellular ATP. ATP induces HB-EGF 
synthesis and release by interacting with the P2 purinergic receptor and through p38 and 
ERK1/2 signaling in response to a challenging environment. A release of ATP acts as an early 
stress response in keratinocytes. 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
The skin is the most outer organ of the mammalian body and so its major function is to 
provide at the epidermis level, a protective barrier against dehydration and insults from the 
environment. The epidermis is mainly composed of keratinocytes which undergo a complex 
differentiation program leading to keratinization. The maintenance of the keratinized barrier is 
a process regulated by keratinocyte proliferation and differentiation, thus when injuries affect 
the epidermal barrier it is crucial to rapidly restore the original tissue. The epidermis is able to 
hyperproliferate in response to several stimuli, including growth factors secreted by the 
keratinocyte itself or by other cells (macrophages, platelets …). More particularly, 
keratinocytes respond to members of the epidermal growth factor (EGF) family. Here, we 
focus on the Heparin-Binding EGF-like Growth Factor (HB-EGF) which is an autocrine 
keratinocyte growth factor (Hashimoto et al., 1994; Raab and Klagsbrun, 1997). Similarly to 
all other members of the EGF family of growth factors, HB-EGF is synthesized as a 
transmembrane protein, proHB-EGF, which can be shed enzymatically by metalloproteases in 
order to release the soluble growth factor (Nishi and Klagsbrun, 2004). At cellular level, it has 
been shown that HB-EGF binds and activates the EGF receptor (EGFR), stimulating the 
keratinocyte proliferation and migration (Nishi and Klagsbrun, 2004). In vivo, Marikovsky et 
al, (1993) have first detected HB-EGF in wound fluid of pigs and HB-EGF also appeared 
after analysis of burn wound fluid from human, who had sustained partial thickness burns 
(Marikovsky et al., 1993; McCarthy et al., 1996). These findings support an important role of 
HB-EGF in skin wound healing and studies reveal that during the re-epithelialization of 
cutaneous wound, HB-EGF stimulates the migration and the proliferation of keratinocytes 
(Hashimoto et al., 1994; Tokumaru et al., 2000).  
 
Cholesterol, an essential component of the plasma membrane involved in membrane structure 
and function, is especially present in specific microdomains called lipid rafts. Previous studies 
from our laboratory have shown that cellular stress with methyl--cyclodextrin, a molecule 
that extracts cholesterol from the plasma membrane and thereby disrupts of lipids rafts, 
strongly induces the expression of HB-EGF in human keratinocytes through the activation of 
p38 mitogen-activated protein kinase (Jans et al., 2004; Mathay et al., 2008). However, the 
mechanisms leading to the expression of HB-EGF have not been fully established. 
 
ATP is known to be the principal intracellular energy source in cells but it has been 
demonstrated that a number of cell types release ATP in the extracellular environment in 
response to mechanical stress or biological activation (Hansen et al., 1993; Pastore et al., 
2007). The first evidence that ATP has extracellular effects was noted in 1929 by Drury & 
Szent-Gyorgyi in their study of the effects of adenine compounds on the heart (Drury and 
Szent-Gyorgyi, 1929). Since this discovery of an involvement in cardiac function, many 
studies have revealed that extracellular ATP contributes to regulate of a variety of biological 
processes, including neurotransmission, smooth muscle contraction, vasodilatation, bone 
metabolism, cell proliferation and differentiation, platelet activation and inflammation 
(Agteresch et al., 1999; Birk et al., 2002; Burnstock and Knight, 2004; Hoebertz et al., 2003; 
Schwiebert and Zsembery, 2003). Despite this knowledge, the mechanisms and physiological 
roles of cellular ATP release are incompletely understood. Once released, the extracellular 
ATP activates P2 purinergic receptors, a family of transmembrane receptors which has been 
divided into two classes: the P2X (ligand-gated ion channels) receptors and the P2Y (G-
protein-coupled) receptors (Boarder and Hourani, 1998). During cutaneous wound healing, 
skin is exposed to extracellular ATP released from platelets and damaged cells (Burrell et al., 
2005; Huang et al., 1989; Weinger et al., 2005) and Dixon et al., (1999) have demonstrated 
that ATP released promotes keratinocyte proliferation. Moreover, during wound healing, 
extracellular ATP acts synergistically with growth factors such as PDGF, TGF- or EGF to 
enhance DNA synthesis and to promote cell proliferation (Wang et al., 1990). Recently, Yin 
et al. demonstrated that ATP released from epithelial cells upon scratch wound was able to 
induce HB-EGF shedding (Yin et al., 2007). 
 
In the present work, we focused on the keratinocyte stress response induced by cholesterol 
depletion using MCD. We demonstrate for the first time that stress conditions like lipid rafts 
disruption by MCD in human keratinocyte, induce a strong release of ATP which can be 
responsible for the expression and shedding of HB-EGF. These results suggest that a release 
of ATP, consecutive to membrane microdomains alterations in keratinocytes, induces HB-
EGF expression and release which can be crucial for epidermal healing and homeostasis. 
 
 
 
 
MATERIALS AND METHODS 
 
Antibodies and chemicals 
MBCD, Suramin, CRM197 and Apyrase were obtained from Sigma-Aldrich (Munich, 
Germany). PD 98059 was from Calbiochem VWR (Leuven, Belgium). Goat anti-human HB-
EGF antibody was obtained from R&D Systems (Abingdon, UK). Mouse anti-phospho-
ERK1/2, rabbit anti-ERK1/2, rabbit anti-p38, anti-phospho-p38 and rabbit anti-human EGFR 
antibody were purchased from Cell Signaling (Leiden, The Netherlands). Rabbit anti-human 
phospho-EGFR Tyr1173 antibody was from Biosource (Nivelles, Belgium). Serum-free 
keratinocyte growth medium was from Lonza (Verviers, Belgium). Serum-free keratinocyte 
complete culture medium (Epilife and HKGS) and keratinocyte autocrine culture medium 
(Epilife without HKGS) were from Cascade Biologics (Mansfield, UK). 
 
Culture of human keratinocytes 
Normal human adult abdominal skin samples were obtained from plastic surgery (Dr Bienfait, 
Clinique St Luc, Namur-Bouge, Belgium). Superficial skin samples were cut with a 
dermatome and keratinocytes were isolated following the trypsin float technique (Wille et al., 
1984). Primary cultures were initiated in KGM2. Proliferating primary cultures were 
trypsinized and keratinocytes were plated into secondary cultures at 6 X 103 cells/cm2 in 
complete culture medium (EpiLife containing HKGS). When the cells covered approximately 
50% of the culture substratum, keratinocytes were switched to an autocrine medium (EpiLife 
alone) which does not contain any growth factor (Minner et al., 2010). In such conditions, 
keratinocytes proliferate autonomously until the confluence of the culture is reached 
concomitantly with cell growth arrest (Poumay and Pittelkow, 1995). All experiments were 
performed at confluence in autocrine culture conditions. 
 
Keratinocytes treatments 
For cholesterol depletion, confluent keratinocyte cultures were incubated in the presence of 
7.5mM MCD for 1 hour followed by incubation in autocrine culture medium for different 
periods (recovery times). This current working MCD concentration has been previously used 
for treatment of keratinocytes (Jans et al., 2004; Lambert et al., 2008) as Jans et al. (2004) 
showed that 1h of MCD is efficient to decrease significantly the concentration of cholesterol 
in keratinocytes. MCD loaded with cholesterol was used as control to avoid any effect not 
resulting from cholesterol extraction (Mathay et al., 2008; Mathay and Poumay, 2010). 
For scratch wound assay, multiple linear scratch wounds were made with a 200 µl pipette tip 
in confluent keratinocytes cultures. Then keratinocytes were washed with PBS to remove 
cellular debris and were incubated in fresh autocrine culture medium for different indicated 
periods (recovery times).  
 
Protein extraction and Western blotting 
Before lysis, cells were washed with phosphate-buffered saline (PBS) and then scraped into 
twice concentrated Laemmli sample buffer (62.5mM Tris–HCl, 2% SDS, 8.7% glycerol, 
0.05% bromophenol blue, 0.2% dithiothreitol). The proteins of the cell lysates were analyzed 
by SDS-polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride 
membranes (GE Healthcare Bio-Sciences, Uppsala, Sweden). Blocking of the membrane in 
PBS/1% Tween 20/5% skimmed milk (blocking buffer) was followed by incubation of the 
membrane with primary antibody diluted in blocking buffer. After three washing steps, the 
membrane was incubated with a HRP-conjugated secondary antibody in blocking buffer. 
Finally, a POD Chemoluminescence Substrate (Roche Diagnostics, Mannheim, Germany) 
was used in order to visualize the recognized protein bands. For the visualisation, an 
ImageQuant 350 (GE Healthcare Bio-Sciences, Uppsala, Sweden) was used. 
 
Measurement of the release of HB-EGF 
Release of HB-EGF in the culture medium was quantified by quantitative sandwich  
enzyme-linked immunosorbent assay (ELISA), using the DuoSet ELISA human HB-EGF kit 
from R&D systems (Abingdon, U.K.). Using a microplate reader (Molecular Devices, 
Sunnyvale, CA, U.S.A.), the optical density was determined at 540 nm (wavelength 
correction at 450 nm). The amount of HB-EGF present in the culture supernatants was 
calculated on the basis of a standard curve with the Softmax Pro 5.2 program. 
 
Lactate dehydrogenase (LDH) release 
Lactate dehydrogenase (LDH) release was measured with the CyTox-ONETM Homogeneous 
Membrane Integrity Assay from Promega (Leiden, Netherlands) according to the 
manufacturer’s protocol. Fluorescence was measured using a fluorescence plate reader 
(Thermo Scientific, Zellick, Belgium) and LDH release was determined using background 
control and positive control cell lysis in Triton X-100 (maximum LDH release). 
 Measurement of extracellular ATP 
Release of extracellular ATP was quantified using the Molecular Probes’ ATP determination 
kit based on the requirement of luciferase for ATP to produce light. After treatment (scratch 
wound or cholesterol depletion), the media were harvested and luciferase activity in the 
presence of these media was measured using a luminometer. The amount of extracellular ATP 
was calculated in reference to a standard curve. 
 
Measurement of cell survival: MTT assay 
MTT solution (Sigma-Aldrich, Bornem, Belgium) dissolved in culture medium was used at a 
concentration of 0.5 mg/ml during 1h. After this incubation, the MTT solution was discarded 
and isopropanol was added to each well for 1h at room temperature. The optical density of 
MTT extraction solution was determined using a microplate reader (550 nm) (Molecular 
Devices, Sunnyvale, CA, U.S.A.).  
 
Cholesterol extraction and quantification  
Cells were scraped into demineralised water before being sonicated (1 minute). Lipids and 
proteins were then separated in chloroform/methanol (2:1). NaCl (0.05 M) was added to the 
organic phase, which was then washed twice with 0.36 M CaCl2/methanol (1:1). 1% Triton X-
100/acetone was added and samples were evaporated in air flow with SpeedVac SC100 
(Thermo Electron Corporation). The extracts were then solubilised with demineralised water 
before measurement of cholesterol. 
Cholesterol was quantified using the Amplex Red Cholesterol Assay Kit (Invitrogen) 
according to the instructions of the manufacturer. 
 
Statistical analysis 
Data were analysed by analysis of variance (ANOVA 1) after testing the homogeneity of 
variance (Bartlett). Post hoc comparisons were performed by pairwise Scheffe’s test 
(*p<0.05, **p<0.01, ***p<0.001). All data represent a mean of three independent 
experiments. 
 
 
 
 
 
 
RESULTS 
 
Lipid rafts disruption in keratinocytes induces the expression and the shedding of HB-
EGF which subsequently binds to the EGFR.  
Previous studies of human keratinocytes have shown that cholesterol depletion by MCD 
induces the activation of p38 and ERK1/2 MAPKs, followed by the expression of proHB-
EGF which has been shown to depend on p38 activity (Mathay et al., 2008). Although 
keratinocytes can produce several growth factors of the EGF family including amphiregulin, 
betacellulin, epiregulin, transforming growth factor- and HB-EGF, it has been shown that 
after treatment for 1h with MCD or 1h of MCD treatment followed by 1h of recovery 
period, HB-EGF is the only member of the family that is rapidly and strongly induced in these 
conditions (Mathay et al., 2010). 
In this work, time-course experiments have been performed after lipid rafts disruption (1h 
MCD) in order to study the recovery period varying from 1 hour to 18 hours in normal 
autocrine culture medium. Figure 1a confirms that protein expression of proHB-EGF is 
indeed expressed following stress conditions in keratinocytes where cholesterol has been 
extracted from the plasma membrane. Immediately after lipid rafts disruption, EGFR and the 
MAPK ERK1/2 and p38 were phosphorylated. However, whereas the phosphorylations of 
EGFR and p38 MAPK were rapidly down-regulated, the ERK1/2 MAPK remained activated 
during the full period of recovery.  
HB-EGF is synthesized as a precursor transmembrane protein that has to be cleaved 
enzymatically to release a soluble growth factor (mature HB-EGF) which then can bind and 
activate the EGFR. Thus, to investigate whether the mature form of HB-EGF was shedded 
and secreted in the cellular environment following cholesterol depletion by MCD, we 
analysed HB-EGF concentration in the culture medium using the ELISA technique. Figure 1b 
illustrates that HB-EGF is mainly secreted after long recovery periods (4h, 8h and 18h) in 
accordance with the maximum of expression of its precursor (1h, 2h, 4h, 8h) as seen in figure 
1a. When the GM6001 metalloprotease inhibitor was added, we observed a decrease in HB-
EGF concentration in the culture medium particularly after 4h, 8h and 18h of recovery 
periods, confirming the implication of metalloprotease in the shedding of HB-EGF (data not 
shown). 
To explore if the mature form of HB-EGF secreted was able to activate the EGFR, cells were 
incubated after cholesterol depletion in the presence of CRM197, a non-toxic mutant of 
diphtheria toxin. CRM197 binds to the proHB-EGF as well as to the mature form of HB-EGF, 
impairing the binding between the EGFR and HB-EGF and subsequently inhibiting the 
mitogenic action of HB-EGF. CRM197 does not bind to other growth factors of the EGF 
family (Mitamura et al., 1995). We focused on the timing where HB-EGF is principally 
secreted and found that after 4h and 8h of recovery times, the phosphorylation of EGFR 
decreases in the presence of CRM197 (Figure 1c), demonstrating that part of the EGFR 
phosphorylation following cholesterol depletion is partly due to receptor binding by HB-EGF 
ligand. Comparing data in Figure 1a, there was a surprising slight increase in the 
phosphorylation of EGFR after 4h of recovery. However generally, the phosphorylation of 
EGFR decreases during the recovery periods.  
These results suggest that perturbation of lipid rafts in keratinocytes plasma membrane of 
induces a stress response which results in the synthesis and shedding of HB-EGF by 
epidermal cells as found during skin wound repair at the margin of the healing epidermis 
(Mathay et al., 2008). A similar pattern of precursor expression and mature form release is 
observed when keratinocytes are wounded in a scratch wound assay (Figure 2a and b), 
indicating that HB-EGF, due to its mitogenic and chemotactic properties, is likely released by 
this cell type in order to participate to healing of the epidermal tissue. To investigate the 
importance of HB-EGF synthesis and release in scratch wound assays, cells were incubated in 
the presence or absence of CRM197. We report that keratinocytes migration was reduced in 
the presence of CRM197, suggesting involvement of HB-EGF in cell migration and 
proliferation (Figure 2c).  
These data suggest that HB-EGF must be considered as a key factor in epidermal stress 
response, as it was already suggested by studies revealing that HB-EGF neutralization with 
CRM197 or with specific neutralizing antibody produces an impaired wound closure (Block 
et al., 2004; Xu et al., 2004). 
                     
  
ATP--S treatment induces HB-EGF synthesis. 
Membrane cholesterol depletion, like other cellular stress, induces an HB-EGF synthesis 
(Mathay et al., 2008). However, the mechanisms leading to the expression of HB-EGF have 
not been fully established although a role for p38 MAPK was identified. It is known that ATP 
signalling in epithelial cells can play a critical role in tissue wound repair since ATP is a 
known extracellular signalling molecule inducing cell proliferation and migration and thus 
promoting wound closure (Klepeis et al., 2004; Weinger et al., 2005). Because the shedding 
of HB-EGF has already been linked to extracellular ATP in other epithelial cells (Yin et al., 
2007), we wondered whether ATP could play a role in the early stages of keratinocyte stress 
response. To investigate whether ATP can contribute directly to cellular protein expression of 
HB-EGF, ATP-S, the nonhydrolyzable ATP analogue, was added to culture medium in 
order to mimic an extracellular ATP release. Figure 3 illustrates that EGFR and ERK1/2 were 
activated 30 minutes after ATP-S stimulation in keratinocytes, followed by expression of 
HB-EGF as detected after 1h and up to 4h. The HB-EGF concentration released in the 
medium were also measured simultaneously, revealing a weak shedding of HB-EGF after 4h 
and 8h only (data not shown), probably due to very low concentrations of released HB-EGF. 
In addition, increasing concentrations of ATP-S stimulate EGFR phosphorylation and HB-
EGF protein expression (Figure 3b).  
This result demonstrates that some extracellular ATP is able to induce the synthesis of HB-
EGF in keratinocytes. Moreover, in good accordance with response to the cholesterol 
depletion, we also observe phosphorylation of EGFR and ERK1/2 after ATP-S treatment, 
suggesting that early cell response after cholesterol depletion could be due to some release of 
ATP by keratinocytes.  
 
Cholesterol depletion induces ATP release from keratinocytes. 
Because extracellular ATP was demonstrated as being able to induce HB-EGF synthesis, the 
question was then to know whether cholesterol depletion could induce some ATP release. In 
order to investigate whether keratinocytes do release ATP after cholesterol depletion, the 
concentrations of ATP were measured in the culture media. Briefly, confluent keratinocyte 
cultures were treated for 1h with MCD followed by incubation in autocrine culture medium 
for different periods of recovery. The culture media were harvested and analysed using the 
luciferase-luciferin ATP bioluminescent assay. Figure 4 illustrates that during incubation 1h 
with MCD, keratinocytes release a high concentration of ATP (355 nM) which corresponds 
to an approximately 21-fold increase over the control condition (16 nM). During the first hour 
of recovery time, we observe a reduced release of extracellular ATP secreted in the culture 
medium compared with the sole incubation with MCD (1h). This release is also seen up to 4 
hours of recovery, and then returns to normal values after 8h of recovery. These results 
strongly suggest that the extracellular ATP released by keratinocytes during cholesterol 
depletion could explain the induced HB-EGF expression after this treatment.   
The question was then to determine whether some cell lysis could be responsible for ATP 
release. To quantify eventual cell lysis, we measured the cytosolic lactate dehydrogenase 
(LDH) activity in the culture media after MCD treatment and during the recovery period. 
The cell membrane is impermeable to LDH, but when the integrity of the plasma membrane is 
altered or disrupted, LDH is rapidly released into the culture medium and therefore can be 
considered as a marker for cell damage. Keratinocyte cultures were grown to confluence and 
treated for 1h with MCD, followed by recovery periods in autocrine culture medium. The 
culture medium was collected and then analysed to measure the amount of LDH activity 
released during the recovery period. Figure 5a shows that MCD did not cause any immediate 
damage to the cell membrane. Some LDH release progressively happened during recovery, 
but its kinetics could not explain the cellular release of ATP, discarding damages to plasma 
membranes as a potential explanation. MTT assays were also performed and showed that 
cholesterol depletion does not affect cellular viability (data not shown). Finally, 
measurements of cholesterol have shown that during recovery periods, cholesterol is 
progressively re-synthesized, reaching a cholesterol concentration in keratinocytes after 17h 
of recovery period that is similar to the initial concentration measured in control conditions 
(Figure 5b).  
 
HB-EGF synthesis induced by lipid rafts disruption is dependent on ATP interaction 
with purinergic receptors. 
Released ATP stimulates cells via the activation of the P2 purinergic receptors in plasma 
membranes (Klepeis et al., 2004). To elucidate whether the expression of HB-EGF observed 
in MCD treatment could be due to the interaction between the extracellular ATP with the P2 
purinergic receptors, we added suramin, a known antagonist of the P2 purinergic receptor.  
Suramin is a non-selective antagonist P2 receptor inhibitor (Dunn and Blakeley, 1988). 
Keratinocyte cultures were incubated 1h with suramin, followed by 1h of MCD treatment 
before washing and incubation for cell recovery in autocrine culture medium containing 200 
µM of suramin (Figure 6a). Results illustrate downregulations of the phosphorylations of 
EGFR and ERK1/2, suggesting that the lipid rafts-induced activation of EGFR and ERK1/2 is 
potentially mediated by the P2 purinergic receptor signalling pathway. On the other hand, the 
p38 MAPK was still phosphorylated in the presence of suramin whilst HB-EGF synthesis was 
completely impaired. This was surprising because previous data have shown that HB-EGF 
synthesis, particularly during short recovery periods after disruption of lipid rafts, is 
dependent on p38 MAPK activity (Mathay et al., 2008). Thus, to control the efficiency of p38 
activity after suramin treatment, the phosphorylation of Hsp27, a down-stream target of p38 
activity in keratinocytes (Garmyn et al., 2001), was checked by Western blot analysis (Figure 
6a). The state of phosphorylation of Hsp27 is in concordance with the activity of p38, 
indicating that the MAPK p38 activity is not affected by suramin. To confirm the implication 
of extracellular ATP in the synthesis of HB-EGF after cholesterol depletion, keratinocytes 
were treated with apyrase. Figure 6b shows that in the presence of apyrase, HB-EGF protein 
expression is also downregulated.  
Because these data indicate that suramin is responsible for some downregulation of ERK1/2 
phosphorylation, followed by a strong decrease in HB-EGF protein expression (Figure 6a), 
we decided to assess whether the MAPK ERK1/2 could participate in the synthesis of HB-
EGF. For this purpose, the MEK inhibitor PD98069 was employed. Interestingly, this 
experiment revealed that inhibition of ERK1/2 phosphorylation by PD98069 decreases 
detection of HB-EGF protein after 1h, 2h and 4h of recovery (Figure 7a). However, since the 
expression of HB-EGF is not completely abolished by this treatment, one can deduce that the 
induction of the synthesis of HB-EGF is probably dependent on an interaction between p38 
and ERK1/2. Indeed, Sharma et al. (2003) observed that a two-way cross-talk between p38 
and ERK1/2 MAPKs in corneal epithelium exists and that, when ERK1/2 pathway is 
interrupted by specific inhibitor, the MAPK p38 is concomitantly up-regulated (Sharma et al., 
2003). Moreover, our previous results showed that the inhibition of p38 did not completely 
abolish the protein expression of HB-EGF after long time (8h and 18h) recovery periods 
(Mathay et al. 2008). For this reason, we analysed the effect of PD98069 combined with the 
p38 MAPK inhibitor PD169316 during the cell response to lipid rafts disruption. Figure 7b 
shows a complete impairing of HB-EGF protein expression in the presence of both inhibitors, 
supporting a two-way cross-talk between p38 and ERK1/2 in controlling the induction of HB-
EGF. 
Altogether our results demonstrate that extracellular ATP acts as an early keratinocytes stress 
response able to induce ERK1/2 signalling through suramin-antagonized receptor (likely the 
P2-purinergic receptor), leading to strong cooperation with p38 in order to induce the 
transient expression of HB-EGF by this cell type. 
 
 
 
 
 DISCUSSION 
 
Previous data from our laboratory have shown that cellular stresses, such as cholesterol 
depletion or oxidative stress, strongly induced the expression of HB-EGF in human 
keratinocytes (Jans et al., 2004; Mathay et al., 2008). However the mechanisms leading to the 
synthesis of HB-EGF have not been fully understood. 
It has been shown that cholesterol depletion using MCD disorganizes the structures of lipid 
rafts (Kabouridis et al., 2000) and initiates keratinocytes signalling pathways including the 
activation of EGFR (Jans et al., 2004; Lambert et al., 2008). The present work precisely 
focuses on the keratinocyte stress response consecutive to cholesterol depletion and which has 
been shown previously to include a strong induction of HB-EGF expression (Mathay et al., 
2008). Here, cells and culture media following cholesterol depletion, during a recovery period 
(Lambert et al., 2008; Mathay et al., 2008) were analysed by Western blotting and ELISA and 
revealed that HB-EGF is mainly released 4h, 8h and 18h following lipid rafts disruption. 
Using the non-toxic mutant of diphtheria toxin, CRM197, we provide evidence that HB-EGF 
secreted in the culture media is likely binding the EGFR, partly inducing its phosphorylation 
after 4h and 8h of recovery. Since HB-EGF expression has been also demonstrated as 
dependent on p38 phosphorylation in stress conditions (Mathay et al., 2008), further 
characterization of the early stress response in keratinocyte was initiated.  
An important role for ATP in keratinocyte proliferation, differentiation and cell-to-cell 
communication has previously been underlined (Burrell et al., 2005; Dixon et al., 1999). In 
vivo, during skin wound healing, keratinocytes are exposed to high levels of ATP released 
from platelets, damaged cells including keratinocytes, and such exposure promotes epidermal 
healing. In addition, because a recent study has shown that extracellular ATP is responsible 
for HB-EGF shedding from epithelial cells after scratch wound (Yin et al., 2007), we 
investigated whether the nonhydrolyzable ATP analogue, ATP--S, was able to induce HB-
EGF expression in autocrine keratinocyte culture model. Interestingly, HB-EGF was indeed 
detected after ATP--S treatment, together with phosphorylation of EGFR and ERK1/2. 
Because related signaling pathways were also activated after MCD treatment, we 
investigated whether keratinocytes do release ATP in their environment after cholesterol 
depletion. Using an ATP bioluminescent assay, we showed that keratinocytes release large 
amount of extracellular ATP upon cholesterol depletion. However, other stresses, like 
oxidative stress or treatment with phorbol ester, which are known to also increase HB-EGF 
expression in keratinocytes, do not induce release of ATP in the culture media (data not 
shown).  
Mechanisms responsible for the release of ATP are multiple and probably differ from cell 
type to another. There are several potential mechanisms, including cytolysis, ATP-binding 
cassette (ABC) protein, neighboring ion channels or exocytosis of vesicles (Bodin and 
Burnstock, 2001; Schwiebert and Zsembery, 2003). Because MCD extracts cholesterol from 
plasma membrane and thereby disrupts lipid rafts, we evaluated the damage to cell membrane 
by measurement of the release of lactate dehydrogenase (LDH) after MCD treatment of 
keratinocytes. No significant release of LDH was observed, suggesting good integrity of the 
cell membrane. Many mitochondrial proteins are found in plasma membrane such as ATP 
synthase complex which are able to generate extracellular ATP in cell environment (Kim et 
al., 2004; Zhao et al., 2004). Kim et al. (2004) have also demonstrated that plasma membrane 
lipid rafts do contain ATP synthase complex. One possible explanation could be that the 
disruption of lipid rafts by MCD causes the activation of ATP synthase. On the other hand, 
Feranchak et al. (2010) have reported the vesicular localisation of ATP in a model of liver cell 
line, suggesting that exocytosis could be involved in ATP release.  
Once released, ATP can be rapidly degraded or interacts and activates in an autocrine or 
paracrine manner the P2 purinergic receptors (Schwiebert and Zsembery, 2003). Among P2 
purinergic receptors, P2Y1 and P2Y2 receptors were identified in the basal layer of the 
epidermis and implicated in keratinocytes proliferation (Dixon et al., 1999; Greig et al., 2003). 
After cholesterol depletion, the released ATP acts as an extracellular mediator by interacting 
with P2 purinergic receptors, leading to HB-EGF synthesis. Indeed, when keratinocytes are 
incubated with suramin, an antagonist of P2 purinergic receptors, followed by MCD 
treatment, the HB-EGF synthesis was abolished as well as the phosphorylation of EGFR and 
ERK1/2.  
The release of extracellular ATP is therefore an early signal after cholesterol depletion, 
identified to be at least partially upstream of the EGFR activation. Recently, Liu et al. have 
suggested a mechanism for the transactivation of the EGFR by the P2Y2 receptor. They have 
identified two SH3-binding domains in the P2Y2 receptor that are necessary for the G-
protein-coupled receptor (GPCR) to bind directly and activate the Src nonreceptor tyrosine 
kinase, leading to Src-dependent transactivation of several receptor tyrosine kinases, 
including the EGFR (Liu et al., 2004). Similarly, Buzzi et al. have suggested that in human 
colon cancer Caco-2 cells stimulated by ATP, GPCR may transactivate the EGFR via 
activation of tyrosine kinases such as Src, or via activation of metalloproteinases to generate 
EGFR ligands (Buzzi et al., 2009). 
 
ERK1/2 is known to be implicated in cell survival and proliferation (Seger and Krebs, 1995). 
Recently, Satoh et al. demonstrated that ERK2 can contribute to wound healing after a partial-
thickness burn (Satoh et al., 2009). Thus we investigated whether the activation of ERK1/2 
could be involved in HB-EGF expression. Although previous data had indicated that HB-EGF 
synthesis was dependent on p38 activation, ERK inhibition appears to partially impair the 
early HB-EGF expression in keratinocytes. These findings provide new insight into the 
signalling pathway by which HB-EGF is expressed after lipid rafts disruption. Our data 
suggest that after p38 and ERK1/2 activation, both MAPKs are involved together or 
independently in the regulation of HB-EGF gene expression. This concurs with studies 
showing that inhibition of one of these two MAPKs impairs wound healing (Satoh et al., 
2009; Sharma et al., 2003). 
 
In conclusion, after lipid raft disruption by cholesterol extraction, keratinocytes respond to 
this cellular stress by release large amounts of extracellular ATP. This release, by interacting 
with the P2 purinergic receptor, induces HB-EGF synthesis and shedding (Figure 8). This 
growth factor is considered as a good marker of the keratinocyte’s response to a challenging 
environment and could even be involved in atopic dermatitis (Mathay et al., 2008). Thus our 
data suggest that the release of extracellular ATP acts as an early stress response in 
cholesterol-depleted keratinocytes. 
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FIGURE LEGENDS 
 
Figure 1: HB-EGF is synthesized and released after cholesterol depletion in human 
keratinocytes cultures. 
a. Confluent keratinocytes were left untreated (Ctl 1h and Ctl 18h) or were treated 1h 
with MCD (7.5 mM) then followed by several recovery periods in culture medium 
(0, 1h, 2h, 4h, 8h and 18h). After each treatment, proteins were extracted and analysed 
by Western blotting using specific antibodies (EGFR, p38, ERK, their phosphorylated 
forms and HB-EGF). b. The culture media were harvested and analysed by enzyme-
linked immunosorbent assay (ELISA) to measure the concentration of HB-EGF 
released after cholesterol depletion. The results shown are representative data obtained 
in three experiments and were analysed by ANOVA 1 after testing the homogeneity of 
variance (Bartlett). Post hoc comparisons were performed by pairwise Scheffe’s test 
(**p<0.01). c. Confluent keratinocytes were left untreated (Ctl 1h and Ctl 18h) or 
treated 1h with MCD (7.5 mM) following by several recovering periods in culture 
medium (2h, 4h, 8h and 18h) in the presence of CRM197 (10 g/ml). After each 
treatment, proteins were extracted and analysed by Western blotting using specific 
antibodies against EGFR and its phosphorylated form.  
 
 
Figure 2: HB-EGF is synthesized and released after scratch wound in human keratinocytes 
cultures. 
a. Confluent keratinocytes were left untreated (Ctl 1h and Ctl 18h) or cultures were wounded 
followed by several recovery periods in culture medium (0, 1h, 2h, 4h, 8h, 18h and 24h). 
Proteins were then extracted and analysed by Western blotting using specific antibodies 
(EGFR, p38, ERK, their phosphorylated forms and HB-EGF). b. The culture media were 
harvested and analysed by enzyme-linked immunosorbent assay (ELISA) to measure the 
concentration of HB-EGF released after cholesterol depletion. The results shown are 
representative data obtained in three experiments and were analysed by ANOVA 1 after 
testing the homogeneity of variance (Bartlett) (*p<0.05, **p<0.01, ***p<0.001). Post hoc 
comparisons were performed by pairwise Scheffe’s test. c. Scratch-wounded keratinocytes 
were incubated in the presence or in absence (Ctl) of CRM197 (10ng/ml). Cells were 
photographed by phase contrast microscopy immediately after the scratch-wound (0h) or after 
18h of recovery period. 
 
 
 
Figure 3: ATP--S treatment induces HB-EGF expression. 
a. Confluent keratinocytes were left untreated (Ctl 30 min and Ctl 8h) or were treated with 
ATP--S (50 µM) during 30 min, 1h, 2h, 4h and 8h and cells lysates were analysed by 
Western blotting using specific antibodies against EGFR, ERK, their phosphorylated forms 
and HB-EGF. b. Confluent keratinocytes were left untreated (Ctl 1h) or treated with several 
concentrations of ATP--S (12.5, 25, 50 or 100 µM) during 1h. Cells lysates were then 
analysed by Western blotting using specific antibodies against EGFR, pEGFR and HB-EGF. 
 
 
 
Figure 4: Cholesterol depletion induces the released of ATP in the culture media. 
Confluent keratinocyte were treated 1 h with MCD (7.5 mM) followed by recovery time (0h, 
1h, 2h, 4h, 8h or 18h). The culture media were harvested for each condition and the 
concentrations of extracellular ATP were analysed using an ATP Bioluminescent Assay Kit. 
The results shown are representative data obtained in four experiments and were analysed by 
ANOVA I after testing the homogeneity of variance (Bartlett). Post Hoc comparisons were 
performed by pairwise Scheffe’s test (*p<0.05, **p<0.01, ***p<0.001). 
 
 
                 
Figure 5: The integrity of plasma membrane is not affected after 1h of MCD treatment. 
Confluent keratinocytes were left untreated (Ctl 1h or Ctl 18h) or were treated 1h with MCD 
(7.5 mM) followed by recovery periods varying from 1 hour to 18 hours in normal autocrine 
culture.  a. Culture media were analysed and the results are expressed as percentages of the 
maximum LDH release and represent the mean absorbance ± SD (n = 3). b. Cholesterol 
content was extracted and quantified with Amplex Red Cholesterol Assay kit. After testing 
the homogeneity of variance (Bartlett), data were analysed by ANOVA 1 and Post Hoc 
comparisons were performed by pairwise Scheffe’s test (*p<0.05, ***p<0.001). 
 
 
 
Figure 6: HB-EGF synthesis after lipid raft disruption is dependent on extracellular ATP 
released in keratinocytes. 
a. Confluent keratinocyte cultures were pretreated 1h with suramin (200 µM) followed by 1h 
of MCD treatment (7.5mM). Then cells were incubated in autocrine culture medium during 
several recovering periods (0, 1h, 2h, 4h, 8h and 18h). After each treatment, proteins were 
extracted and analysed by Western blotting using specific antibodies against EGFR, p38, 
ERK, HSP27 and their phosphorylated forms and HB-EGF. 
b. Confluent keratinocyte cultures were treated 1h with 1h MCD (7.5mM) in the presence of 
apyrase (10U/ml) or the vehicle. Then cells were incubated in autocrine culture medium 
during several recovering periods (0, 1h, 2h, 4h, 8h and 18h) in the presence of apyrase 
(10U/ml) or the vehicle. After each treatment, proteins were extracted and analysed by 
Western blotting using specific antibodies against EGFR, p38, ERK, and their phosphorylated 
forms and HB-EGF. 
 
 
 
Figure 7: Early HB-EGF protein expression induced by disruption of lipid rafts is dependent 
on ERK and p38 MAPK activity. 
a. Confluent keratinocyte cultures were left untreated or were pretreated 1h with the ERK 
inhibitor, the PD98069 (2 µM) then left untreated or treated with MCD (7.5mM) for 1h in 
the presence of PD98069 (2 µM) or the vehicle. Then cells were incubated in autocrine 
culture medium during several recovering periods (0, 1h, 2h, 4h, 8h and 18h) in the presence 
of PD98069 (2 µM) or the vehicle. Cells lysates were then analysed by Western blotting using 
specific antibodies against EGFR, ERK, their phosphorylated forms and HB-EGF.  
b. Confluent keratinocyte cultures were pretreated 1h with PD98069 (2 µM) and PD169316 
(15 µM). Then cultures were treated 1h with MCD (7.5mM) in the presence of both 
inhibitors which were also part of the recovery medium (0, 1h, 2h, 4h, 8h and 18h). Cells 
lysates were then analysed by Western blotting. 
 
 
Figure 8: HB-EGF synthesis and release induced by MCD treatment is controlled by 
extracellular ATP and involves both p38 and ERK1/2 signaling pathways in keratinocytes. 
After cholesterol depletion, keratinocytes release large amounts of extracellular ATP. By 
interaction with P2 purinergic receptors, ATP induces EGFR phosphorylation, HB-EGF 
synthesis and release through signaling pathways involving p38 and ERK1/2. Once released, 
HB-EGF further activates EGFR. 
 
 
 
